CA2263729C - Process for producing mammals with defined genetic properties - Google Patents
Process for producing mammals with defined genetic properties Download PDFInfo
- Publication number
- CA2263729C CA2263729C CA002263729A CA2263729A CA2263729C CA 2263729 C CA2263729 C CA 2263729C CA 002263729 A CA002263729 A CA 002263729A CA 2263729 A CA2263729 A CA 2263729A CA 2263729 C CA2263729 C CA 2263729C
- Authority
- CA
- Canada
- Prior art keywords
- cells
- mice
- blastocysts
- embryos
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 65
- 230000008569 process Effects 0.000 title claims abstract description 27
- 241000124008 Mammalia Species 0.000 title claims abstract description 16
- 230000002068 genetic effect Effects 0.000 title claims abstract description 16
- 210000004027 cell Anatomy 0.000 claims abstract description 228
- 210000002459 blastocyst Anatomy 0.000 claims abstract description 61
- 208000035199 Tetraploidy Diseases 0.000 claims abstract description 43
- 210000004602 germ cell Anatomy 0.000 claims abstract description 21
- 230000009261 transgenic effect Effects 0.000 claims abstract description 19
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 10
- 210000001671 embryonic stem cell Anatomy 0.000 claims abstract description 5
- 241000699670 Mus sp. Species 0.000 claims description 60
- 210000002257 embryonic structure Anatomy 0.000 claims description 49
- 239000013612 plasmid Substances 0.000 claims description 9
- 238000012239 gene modification Methods 0.000 claims description 8
- 230000005017 genetic modification Effects 0.000 claims description 8
- 235000013617 genetically modified food Nutrition 0.000 claims description 8
- 238000000520 microinjection Methods 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 33
- 238000000338 in vitro Methods 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 description 28
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- 230000002776 aggregation Effects 0.000 description 17
- 238000004220 aggregation Methods 0.000 description 17
- 238000002347 injection Methods 0.000 description 16
- 239000007924 injection Substances 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 13
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 13
- 108090000123 Fos-related antigen 1 Proteins 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 239000013598 vector Substances 0.000 description 11
- 108700028369 Alleles Proteins 0.000 description 10
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 102000003817 Fos-related antigen 1 Human genes 0.000 description 8
- 108700019146 Transgenes Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 101150066555 lacZ gene Proteins 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 5
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 5
- 238000010363 gene targeting Methods 0.000 description 5
- 238000011740 C57BL/6 mouse Methods 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 206010068051 Chimerism Diseases 0.000 description 3
- 101100351020 Mus musculus Pax5 gene Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000011721 B6CBAF1 mouse Methods 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108010044467 Isoenzymes Proteins 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229940009976 deoxycholate Drugs 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 108010079892 phosphoglycerol kinase Proteins 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 208000003580 polydactyly Diseases 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 238000011830 transgenic mouse model Methods 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 108700003860 Bacterial Genes Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101150091556 Igf2r gene Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 101100447536 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pgi-1 gene Proteins 0.000 description 1
- 241000577979 Peromyscus spicilegus Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 101100351021 Xenopus laevis pax5 gene Proteins 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 210000001840 diploid cell Anatomy 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 210000002219 extraembryonic membrane Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000006543 gametophyte development Effects 0.000 description 1
- 238000003208 gene overexpression Methods 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 108700025907 jun Genes Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 101150017984 mpr gene Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 229950010131 puromycin Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 208000027223 tetraploidy syndrome Diseases 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000011816 wild-type C57Bl6 mouse Methods 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19632532A DE19632532A1 (de) | 1996-08-13 | 1996-08-13 | Verfahren zur Herstellung von Säugetieren mit definierten genetischen Eigenschaften |
| DE19632532.3 | 1996-08-13 | ||
| PCT/EP1997/004352 WO1998006834A1 (de) | 1996-08-13 | 1997-08-09 | Verfahren zur herstellung von säugetieren mit definierten genetischen eigenschaften |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2263729A1 CA2263729A1 (en) | 1998-02-19 |
| CA2263729C true CA2263729C (en) | 2006-06-27 |
Family
ID=7802466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002263729A Expired - Lifetime CA2263729C (en) | 1996-08-13 | 1997-08-09 | Process for producing mammals with defined genetic properties |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6492575B1 (enExample) |
| EP (1) | EP0928332B1 (enExample) |
| JP (2) | JP2000516463A (enExample) |
| AT (1) | ATE281516T1 (enExample) |
| CA (1) | CA2263729C (enExample) |
| DE (2) | DE19632532A1 (enExample) |
| ES (1) | ES2231883T3 (enExample) |
| PT (1) | PT928332E (enExample) |
| WO (1) | WO1998006834A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5523226A (en) * | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
| CN1083687C (zh) * | 1999-02-15 | 2002-05-01 | 湖南师范大学 | 四倍体鱼的培育方法 |
| AU2001249525A1 (en) * | 2000-03-28 | 2001-10-08 | Ludwig Institute For Cancer Research | Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof |
| US6784336B2 (en) * | 2000-09-20 | 2004-08-31 | Whitehead Institute For Biomedical Research | Method of producing mutant mice |
| EP1452093A4 (en) * | 2001-11-15 | 2007-08-15 | Kirin Brewery | CHIMESE NON-MENTAL ANIMAL |
| JP4364474B2 (ja) | 2002-02-15 | 2009-11-18 | 大学共同利用機関法人情報・システム研究機構 | 哺乳動物において機能的なトランスポゾン |
| US7365182B2 (en) * | 2002-05-01 | 2008-04-29 | Michigan State University | Plant vernalization independence (VIP) genes, proteins, and methods of use |
| GB0210539D0 (en) * | 2002-05-08 | 2002-06-19 | Univ Edinburgh | Control of es cell self renewal and lineage specification, and medium therefor |
| US7723565B2 (en) * | 2004-01-07 | 2010-05-25 | Wisconsin Alumni Research Foundation | Vernalization-related molecules and methods for inducibly-conferring epigenetic changes |
| ATE536374T1 (de) | 2006-09-01 | 2011-12-15 | Therapeutic Human Polyclonals Inc | Erhöhte expression von humanem oder humanisiertem immunglobulin bei nicht-humanen transgenen tieren |
| CA2710567A1 (en) | 2007-12-31 | 2009-07-16 | Baxter Healthcare S.A. | Transgenic non-human animals expressing human blood clotting factors |
| NZ609908A (en) * | 2008-10-27 | 2014-07-25 | Baxter Int | Models of thrombotic thrombocytopenic purpura and methods of use thereof |
| WO2011005580A2 (en) * | 2009-06-23 | 2011-01-13 | The Scripps Research Institute | Adult animals generated from induced pluripotent cells |
| US20110072524A1 (en) | 2009-08-04 | 2011-03-24 | Baxter International Inc. | Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A |
| US10662256B2 (en) | 2010-07-26 | 2020-05-26 | Trianni, Inc. | Transgenic mammals and methods of use thereof |
| RU2580017C2 (ru) | 2010-07-26 | 2016-04-10 | Трианни, Инк. | Трансгенные животные и способы применения |
| US10793829B2 (en) | 2010-07-26 | 2020-10-06 | Trianni, Inc. | Transgenic mammals and methods of use thereof |
| WO2015013575A2 (en) * | 2013-07-25 | 2015-01-29 | Ingenious Targeting Laboratory, Inc. | Knockout mice derived from site specific recombinase |
| WO2017095939A1 (en) | 2015-12-03 | 2017-06-08 | Trianni, Inc. | Enhanced immunoglobulin diversity |
| IL260743B2 (en) | 2016-02-04 | 2024-03-01 | Trianni Inc | Advanced production of antibodies |
| US20200390072A1 (en) * | 2018-03-02 | 2020-12-17 | Generation Bio Co. | Identifying and characterizing genomic safe harbors (gsh) in humans and murine genomes, and viral and non-viral vector compositions for targeted integration at an identified gsh loci |
| EP4144857A4 (en) * | 2020-03-06 | 2024-02-28 | Mingceler Biotechnology Co., Ltd. | PROCESS FOR PREPARING AN ANIMAL |
| US20240374761A1 (en) | 2021-05-05 | 2024-11-14 | Radius Pharmaceuticals, Inc. | Animal model having homologous recombination of mouse pth1 receptor |
| CN115466718B (zh) * | 2022-08-09 | 2023-07-14 | 广州明迅生物科技有限责任公司 | 雌性胚胎干细胞及其制备方法和应用 |
| CN118185862B (zh) * | 2024-05-16 | 2024-08-09 | 中国科学院昆明动物研究所 | 一种小鼠四倍体器官的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ244306A (en) * | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
| DE4228162C1 (de) * | 1992-08-25 | 1994-01-13 | Rajewsky Klaus Dr | Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern |
| US5523226A (en) | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
| US5907080A (en) * | 1995-11-30 | 1999-05-25 | Nexia Biotechnologies, Inc. | Method for development of transgenic dwarf goats |
| US6331406B1 (en) | 1997-03-31 | 2001-12-18 | The John Hopkins University School Of Medicine | Human enbryonic germ cell and methods of use |
-
1996
- 1996-08-13 DE DE19632532A patent/DE19632532A1/de not_active Withdrawn
-
1997
- 1997-08-09 DE DE59712068T patent/DE59712068D1/de not_active Expired - Lifetime
- 1997-08-09 JP JP10509392A patent/JP2000516463A/ja not_active Withdrawn
- 1997-08-09 ES ES97936698T patent/ES2231883T3/es not_active Expired - Lifetime
- 1997-08-09 PT PT97936698T patent/PT928332E/pt unknown
- 1997-08-09 WO PCT/EP1997/004352 patent/WO1998006834A1/de not_active Ceased
- 1997-08-09 US US09/242,406 patent/US6492575B1/en not_active Expired - Lifetime
- 1997-08-09 CA CA002263729A patent/CA2263729C/en not_active Expired - Lifetime
- 1997-08-09 EP EP97936698A patent/EP0928332B1/de not_active Expired - Lifetime
- 1997-08-09 AT AT97936698T patent/ATE281516T1/de active
-
2006
- 2006-08-10 JP JP2006218386A patent/JP4129472B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0928332A1 (de) | 1999-07-14 |
| ATE281516T1 (de) | 2004-11-15 |
| ES2231883T3 (es) | 2005-05-16 |
| JP2006296440A (ja) | 2006-11-02 |
| PT928332E (pt) | 2005-01-31 |
| DE19632532A1 (de) | 1998-02-19 |
| WO1998006834A1 (de) | 1998-02-19 |
| EP0928332B1 (de) | 2004-11-03 |
| DE59712068D1 (de) | 2004-12-09 |
| CA2263729A1 (en) | 1998-02-19 |
| US6492575B1 (en) | 2002-12-10 |
| JP4129472B2 (ja) | 2008-08-06 |
| US20020178457A1 (en) | 2002-11-28 |
| JP2000516463A (ja) | 2000-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2263729C (en) | Process for producing mammals with defined genetic properties | |
| Wang et al. | Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection | |
| Wall et al. | Transgenic farm animals—a critical analysis | |
| Wilmut et al. | Genetic manipulation of mammals and its application in reproductive biology | |
| Béjar et al. | An ES-like cell line from the marine fish Sparus aurata: characterization and chimaera production | |
| US20030177512A1 (en) | Method of genetically altering and producing allergy free cats | |
| US20110061119A1 (en) | Method of producing non-human mammals | |
| US6281408B1 (en) | Efficient method for production of compound transgenic animals | |
| Fedorov et al. | A comparison of the germline potential of differently aged ES cell lines and their transfected descendants | |
| Khillan et al. | Preparation of animals with a high degree of chimerism by one-step coculture of embryonic stem cells and preimplantation embryos | |
| US20050125853A1 (en) | Method for generating genetically modified animals | |
| Rossant et al. | Genome manipulation in embryonic stem cells | |
| Doetschman | Gene transfer in embryonic stem cells | |
| US20170107540A1 (en) | Method of genetically altering and producing allergy free cats | |
| Singh et al. | Transgenic animals | |
| US7132282B2 (en) | Genetic modification of C57 mice | |
| PT1449920E (pt) | Murganhos transgénicos utilizados como modelo para patologias humanas com origem em células estaminais | |
| Brenin et al. | Transgenic technology: an overview of approaches useful in surgical research | |
| CA2264450A1 (en) | Methods for monitoring heterologous sex chromosomes | |
| Ladiges et al. | Transgenic animals in toxicology | |
| Gwatkin | Manipulation of mammalian development | |
| WO2003106651A2 (en) | Spermatogonial cell line | |
| Kim et al. | A new embryonic stem cell line with germ-line competence in the FvB/N background | |
| WO2002022789A1 (en) | Process for producing normal parenchymal cells, tissue or organ by bioincubator | |
| JPH1033087A (ja) | グルタミン酸トランスポーター遺伝子機能欠損非ヒト動物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20170809 |